Anfernee Simons
Signed with the 76ers in July 2026 free agency. Philadelphia's perimeter is crowded with Maxey, Edgecombe, and Brown, so his scoring likely comes in a bench role.NBA.com 2026 offseason deals
Three-pointers made per game — 25-26, league-wide.
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 18-19 | n/a |
| 19-20 | #333 |
| 20-21 | #318 |
| 21-22 | #132 |
| 22-23 | #86 |
| 23-24 | #85 |
| 24-25 | #96 |
| 25-26 | #205 |
| 26-27 Projection | #191 |
Stat Trend
Track role, durability, and category growth by season. Scoring: 9-category
Full data
| Season | PTS |
|---|---|
| 18-19 | 3.8 |
| 19-20 | 8.3 |
| 20-21 | 7.8 |
| 21-22 | 17.3 |
| 22-23 | 21.1 |
| 23-24 | 22.6 |
| 24-25 | 19.3 |
| 25-26 | 14.3 |
| 26-27 Projection | 14.2 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 15.5 |
| Nov 2025 | 12.9 |
| Dec 2025 | 12.1 |
| Jan 2026 | 15.6 |
| Feb 2026 | 15.2 |
| Feb 2026 | 27 |
| Oct 2026 | 6.3 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
PHI — all five positions, best player first at each spot.
Season History
9-categoryNBA profile
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 28 | PHI | 58 | 0 | 24.6 | #191 | 0.61 | 14.2 | 2.4 | 2.8 | 0.6 | 0.1 | 2.5 | 43.3% | 11.9 | 90.6% | 1.7 | 1.3 |
| 26-27 | 27 | PHI | 3 | 0 | 20.8 | n/a | n/a | 6.3 | 2 | 0.7 | 0.3 | 0 | 1.3 | 28.6% | 7 | 60.0% | 1.7 | 0.7 |
| 25-26 | 27 | CHI | 55 | 0 | 24.9 | #205 | -0.14 | 14.3 | 2.5 | 2.4 | 0.5 | 0.1 | 2.7 | 44.0% | 11.8 | 89.6% | 1.4 | 1.2 |
| 24-25 | 26 | POR | 70 | 0 | 32.7 | #96 | 2.79 | 19.3 | 2.7 | 4.8 | 0.9 | 0.1 | 3.1 | 42.6% | 16.1 | 90.2% | 2.8 | 2 |
| 23-24 | 25 | POR | 46 | 0 | 34.4 | #85 | 3.18 | 22.6 | 3.6 | 5.5 | 0.5 | 0.1 | 3.4 | 43.0% | 18.2 | 91.6% | 3.9 | 2.7 |
| 22-23 | 24 | POR | 62 | 0 | 35 | #86 | 3.08 | 21.1 | 2.6 | 4.1 | 0.7 | 0.2 | 3.4 | 44.7% | 16.9 | 89.4% | 2.9 | 2.1 |
| 21-22 | 23 | POR | 57 | 0 | 29.5 | #132 | 1.69 | 17.3 | 2.6 | 3.9 | 0.5 | 0.1 | 3.1 | 44.3% | 14 | 88.8% | 2 | 2 |
| 20-21 | 22 | POR | 64 | 0 | 17.3 | #318 | -2.99 | 7.8 | 2.2 | 1.4 | 0.3 | 0.1 | 1.9 | 41.9% | 6.3 | 80.7% | 0.9 | 0.7 |
| 19-20 | 21 | POR | 70 | 0 | 20.7 | #333 | -3.52 | 8.3 | 2.2 | 1.4 | 0.4 | 0.1 | 1.1 | 39.9% | 7.7 | 82.6% | 1.3 | 0.9 |
| 18-19 | 20 | POR | 20 | 0 | 7 | n/a | n/a | 3.8 | 0.7 | 0.7 | 0.1 | 0 | 0.5 | 44.4% | 3.2 | 56.3% | 0.8 | 0.6 |